Death Caused By Improper Relenza Use: Drug Maker

Inappropriate use of the anti-flu medication Relenza has been linked with at least one death, drug maker GlaxoSmithKline says in a letter sent to doctors. The letter was posted online Friday by the U.S. Food and Drug Administration.

The death occurred after the drug was reformulated into a liquid form, an action not recommended by the FDA. Glaxo said Relenza should only be used in the prescribed manner. The letter didn't provide any details about the person who died, the Associated Press reported.

Relenza, which comes in powder form to be used with a special inhaler device, is approved by the FDA to treat symptoms of seasonal flu when taken within two days of the start of the flu.

Millions of doses of Relenza and Roche's Tamiflu have been stockpiled by the United States, the AP reported.

More on This

• Man dies of bird flu in southwest China: Xinhua
• Bird flu researchers suspend study of mutations
• More labs close to deadly bird flu mutations
• Bird flu virus doesn't jump between humans: China

Tags

• Influenza
• Political Issues

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Do you really want to post anonymously?

Are You a Member? Log InConnect your comment to your member profile. It only takes a second! Not a Member? Join Now!You'lll be automatically notified when someone else comments on your post.

Tell us what you think Write your comment here *

Leave this field blank

Receive email notifications of new comments Email Addresss

Sign me up for EmpowHER's FREE Newsletter!

Type in the characters above *

By hitting submit, you agree to EmpowHER's terms of service and privacy policy